TNFRSF21 and amyotrophic lateral sclerosis: Thus, our findings support the notion that DR6—expressed at the surface of MNs—not only contribute to the demise of these cells in response to ALS astrocytes, but may also modulate MN vulnerability to this astrocyte-derived insult.